Trusted by Leading Research & Pharma Institutions

Engineering of Bacterial Chassis for Biosynthesis

Transform microbial cell factories into high-performance biosynthesis platforms. Our comprehensive bacterial chassis engineering services combine cutting-edge genome editing, metabolic optimization, and systems biology approaches to deliver production-ready strains for industrial biomanufacturing.

CRISPR-Enabled Engineering

DBTL Optimization

Scalable Production

Learn More

Trusted by leading research and pharmaceutical institutions

Harvard

Pfizer

MIT

Roche

Stanford

Merck

Why Choose Us

Multi-omics guided metabolic optimization

Automated high-throughput screening

Industrial-scale fermentation support

Expert consultation included

Genome Engineering

CRISPR-enabled precision editing

Metabolic Optimization

Systems biology approaches

Scale-Up Support

From lab to industrial fermentation

Production Increase

10-50x

Service Overview

Comprehensive Bacterial Chassis Engineering

Our platform integrates multi-omics analysis, computational metabolic modeling, and automated strain construction to deliver optimized bacterial chassis for your biosynthesis needs.

Genome-Scale Engineering

Advanced CRISPR-Cas systems enable precise, multiplexed genome modifications. Our optimized protocols achieve high editing efficiency while maintaining genetic stability essential for industrial applications.

Multiplex gene knockout/knock-in
Base editing and prime editing
Chromosomal integration up to 20 kb

Metabolic Pathway Optimization

Systems biology approaches combined with high-throughput screening enable comprehensive metabolic rewiring. We balance precursor supply, cofactor availability, and product flux for maximum yield.

Genome-scale metabolic modeling
Dynamic pathway regulation
Cofactor engineering

Multi-Omics Integration

Genomics, transcriptomics, proteomics, and metabolomics data guide rational strain design decisions.

High-Throughput Screening

Automated FACS, microtiter plates, and biosensor-based screens accelerate strain identification.

Adaptive Evolution

Laboratory evolution enhances strain robustness under industrial process conditions.

Technology Platform

Advanced Engineering Technologies

Industry-leading tools and methodologies ensure optimal strain performance for every project.

CRISPR-Cas Systems

Next-generation CRISPR tools enable precise, scarless genome modifications with high efficiency. Our optimized protocols support multiplex editing for complex pathway engineering.

CRISPR-Cas9 CRISPRi Base Editing

Computational Modeling

Genome-scale metabolic models combined with machine learning predict optimal engineering targets. Our platform integrates constraint-based and kinetic modeling for comprehensive strain design.

GEMs FBA ML Prediction

High-Throughput Screening

Automated screening platforms evaluate thousands of strains in parallel. Biosensor-based selection and FACS enable rapid identification of high-producing variants.

FACS Biosensors Automation

Genome Engineering Tools

CRISPR Multiplex gene editing

Integrase Site-specific chromosomal integration

Transposon Random mutagenesis libraries

ALE Adaptive laboratory evolution

Analysis & Optimization

RNA-Seq Transcriptomic analysis

LC-MS Metabolomic profiling

Proteomics Protein expression analysis

Flux Metabolic flux analysis

Specifications

Flexible Options for Diverse Needs

Comprehensive specifications to meet your research and industrial requirements.

Parameter	Standard Service	Premium Service	Custom Development
Host Organisms	E. coli, B. subtilis	C. glutamicum, P. putida	Any bacterial species
Editing Complexity	Up to 3 simultaneous edits	Up to 10 simultaneous edits	Multiplex automation
Metabolic Models	Standard genome-scale	Custom compartmented models	Kinetic integration
Screening Capacity	1,000-10,000 variants	10,000-100,000 variants	100,000+ variants
Deliverables	2-3 strains + QC report	5-10 strains + full data	Full R&D package

Workflow

Streamlined DBTL Process

Our proven 6-step workflow ensures continuous improvement through Design-Build-Test-Learn cycles.

Design

Multi-omics analysis and computational modeling

Build

CRISPR-enabled strain construction

Test

High-throughput screening and analytics

Learn

Data analysis and machine learning

Iterate

Cycle optimization based on insights

Deliver

Final strain and scale-up support

Applications

Diverse Industrial Applications

Our bacterial chassis engineering supports research and production across multiple sectors.

Bio-based Chemicals Production

Engineered bacterial chassis for sustainable production of commodity and specialty chemicals. Our platforms enable high-titer, cost-effective biomanufacturing of diverse chemical classes.

Organic acids (lactic, succinic, itaconic acid)
Amino acids (lysine, glutamate, tryptophan)
Terpenoids and aromatics
Biopolymers (PHA, PLA)

50+

Chemical products demonstrated

Pharmaceutical Manufacturing

GRAS-status bacterial chassis for production of pharmaceutical intermediates, APIs, and biologics. Compliance with regulatory requirements for clinical and commercial manufacturing.

Antibiotic precursors
Vitamin biosynthesis
Recombinant proteins
Vaccine antigens

GMP

Quality standards available

Food and Nutritional Ingredients

Sustainable production of food-grade compounds using food-safe bacterial platforms. Clean label ingredients produced through precision fermentation.

Flavors and fragrances
Nutritional supplements
Sweeteners
Enzymes for food processing

GRAS

Food safety certifications

Testimonials

What Our Clients Say

Trusted by researchers and companies worldwide for quality and reliability.

"The metabolic optimization dramatically improved our amino acid production titer. The team's expertise in systems biology and their comprehensive DBTL approach delivered results beyond our expectations."

Senior Scientist

Industrial Amino Acid Producer

"Fast turnaround and excellent technical support throughout the project. The CRISPR multiplexing capability allowed us to make complex pathway modifications efficiently. Highly recommended for metabolic engineering projects."

Research Director

Synthetic Biology Startup

"We've used this service for multiple projects in biopolymer production. Consistent quality and professional service every time. The scale-up support was particularly valuable for our industrial fermentation needs."

Lead Researcher

Biomaterials Company

Scientific Literature

Scientific Foundation

Our platform is backed by peer-reviewed research in bacterial chassis engineering.

85 Citations

A synthetic methylotrophic Escherichia coli as a chassis for bioproduction from methanol

Reiter MA, Bradley T, Büchel LA, Keller P, et al. Nature Catalysis. 2024.

Development of an E. coli strain growing on methanol at 4.3h doubling time, enabling bioconversion of methanol to value-added products.

View DOI

156 Citations

Engineering and modification of microbial chassis for systems and synthetic biology

Chen X, Zhou K, Zhang D, Mu W. Current Opinion in Biotechnology. 2018.

Comprehensive review of top-down and bottom-up strategies for microbial chassis construction and engineering.

View DOI

89 Citations

Advances on systems metabolic engineering of Bacillus subtilis as a chassis cell

Xiang M, Kang Q, Zhang D. Synthetic Systems Biotechnology. 2020.

Review of systems biology, synthetic biology, and evolution-based engineering approaches for B. subtilis chassis optimization.

View DOI

47 Citations

Engineering a Xylose-Utilizing Synechococcus elongatus Chassis for 3-Hydroxypropionic Acid Biosynthesis

Yao J, Wang J, Ju Y, et al. ACS Synthetic Biology. 2022.

Development of engineered cyanobacterial chassis for photomixotrophic 3-HP production with 14-fold improvement.

View DOI

12 Citations

Production of chemicals by metabolically engineered Escherichia coli

Jang G, Kim MJ, Lee SY. Current Opinion in Biotechnology. 2025.

Review of systems metabolic engineering strategies for expanding E. coli molecular repertoire and optimizing TRY metrics.

View DOI

FAQ

Frequently Asked Questions

Find answers to common questions about our bacterial chassis engineering services.

What bacterial species can you engineer?

We specialize in engineering E. coli, Bacillus subtilis, Corynebacterium glutamicum, and Pseudomonas putida. For other bacterial species, please consult with our team. Our CRISPR-enabled platform can be adapted for most Gram-negative and Gram-positive bacteria with available transformation protocols.

How do you ensure genetic stability of engineered strains?

Genetic stability is ensured through marker-free genome modifications, chromosomal integration of pathways, and characterization of strains over multiple generations. We validate stability through serial passage experiments and provide detailed characterization reports for each delivered strain.

What is the typical improvement in production titer?

Improvement varies depending on the starting strain, pathway complexity, and target product. Through comprehensive DBTL optimization, we typically achieve 10-50x improvement in production titer compared to baseline strains. Many projects have demonstrated industrial-relevant titers exceeding 50 g/L.

Do you provide scale-up support?

Yes, we offer comprehensive scale-up support from shake flask to industrial bioreactor conditions. Our services include fermentation process development, oxygen transfer optimization, and scalability assessment. We work with manufacturing partners to ensure successful technology transfer.

What analytical services are included?

Standard deliverables include HPLC/GC analysis for product quantification, residual substrate analysis, and pathway intermediate profiling. Premium packages include comprehensive multi-omics analysis (transcriptomics, proteomics, metabolomics) and full genome sequencing of engineered strains.

How do you handle intellectual property?

All engineered strains and associated data are transferred to the client with full IP rights. We maintain strict confidentiality throughout the project. Our service agreements include clear IP ownership terms, and we never use client-specific information for other projects without explicit permission.

Can you work with proprietary pathways?

Yes, we regularly work with client-provided biosynthetic pathways under strict confidentiality. Our platform accommodates both publicly available and proprietary pathway designs. We can also assist with pathway design optimization based on our proprietary enzyme engineering capabilities.

What quality control standards do you follow?

All strains undergo rigorous quality control including genome sequencing verification, phenotypic characterization, and stability testing. For pharmaceutical applications, we follow cGMP guidelines and can provide documentation for regulatory submissions. Our QC protocols exceed industry standards.

Do you offer strain banking services?

Yes, we provide comprehensive cell banking services including Master Cell Bank (MCB) and Working Cell Bank (WCB) preparation. Banks are characterized for identity, purity, stability, and performance. We maintain backup stocks for an agreed period and can transfer banking protocols for client-side banking.

Ready to Start Your Project?

Get a customized quote for your Bacterial Chassis Engineering project. Our experts will respond within 24 hours.

No obligation

24h response

Expert consultation

Request a Quote

Engineering of Bacterial Chassis for Biosynthesis

Why Choose Us

Genome Engineering

Metabolic Optimization

Scale-Up Support

Comprehensive Bacterial Chassis Engineering

Genome-Scale Engineering

Metabolic Pathway Optimization

Multi-Omics Integration

High-Throughput Screening

Adaptive Evolution

Ready to Optimize Your Production Strain?

Advanced Engineering Technologies

CRISPR-Cas Systems

Computational Modeling

High-Throughput Screening

Genome Engineering Tools

Analysis & Optimization

Flexible Options for Diverse Needs

Streamlined DBTL Process

Design

Build

Test

Learn

Iterate

Deliver

Diverse Industrial Applications

Bio-based Chemicals Production

Pharmaceutical Manufacturing

Food and Nutritional Ingredients

What Our Clients Say

Scientific Foundation

A synthetic methylotrophic Escherichia coli as a chassis for bioproduction from methanol

Engineering and modification of microbial chassis for systems and synthetic biology

Advances on systems metabolic engineering of Bacillus subtilis as a chassis cell

Engineering a Xylose-Utilizing Synechococcus elongatus Chassis for 3-Hydroxypropionic Acid Biosynthesis

Production of chemicals by metabolically engineered Escherichia coli

Frequently Asked Questions

Ready to Start Your Project?

Recommended Services

Related Resources